Call Us Now: (240) 429 2177

Health

COVID-19: Coalition Against COVID-19 (CACOVID) donates 150-bed Isolation Center, multi-million Naira Medical Equipment to Lagos State
June 29, 2020 | 0 Comments
The Governor commended the Coalition’s efforts in mobilising resources quickly to support emergency responses.

The Private Sector led Coalition Against COVID-19 (CACOVID) has donated a 150-bed fully equipped  isolation facility with medical equipment worth millions of naira to the Lagos State Government, to provide support in the fight against the virus within the state.

Speaking at the commissioning of the Yaba Isolation center, Lagos State Governor, Babajide Sanwo-Olu noted that the isolation center would further strengthen the state’s healthcare system in dealing with the challenges of the Pandemic as the state currently leads the toll of Nigeria’s COVID-19 infections with over 10,000 confirmed cases.

The Governor commended the Coalition’s efforts in mobilising resources quickly to support emergency responses and pledged that the donated facility would be used to provide adequate treatment to those who are infected and help to stop the overall spread of the virus within the state.

He urged all citizens to continue to take responsibility and follow directives of the government and health professionals towards reducing the spread of the virus and saving lives across communities.

“We need to take responsibility because the virus knows no race, ethnicity, religion or boundary. We need to take responsibility for our loved ones by wearing face mask, maintaining social distancing and hand hygiene to reduce morbidity and mortality,” the governor said.

He further disclosed plans by the State Government to build an International Infectious Disease Research Centre, Doctors’ quarters and permanent isolation wards at the Mainland Infectious Disease Hospital, Yaba as part of Lagos COVID19 response and other infectious disease preparedness in post COVID19 era.

In his remarks, the State Commissioner for Health, Prof. Akin Abayomi, said that the center was the sixth facility in the state dedicated to the treatment of COVID-19 patients, and is coming onboard at a time when the state is ramping up its testing capacity.

He further said the 150-bed facility donated by CACOVID would be used for the management of moderate to severe COVID-19 patients and would assist in admitting and providing care for more patients.

Also speaking at the event, the Central Bank Governor, Mr. Godwin Emefiele, said that collaboration between the private sector and government was vital to prevent the spread of the virus and save the lives of the citizens,

He further said that the center would enhance the state’s healthcare system and the management of COVID-19 within the state.

According to him, N29 billion has been donated so far by members of the coalition towards supporting government’s efforts in fighting the COVID-19 pandemic and that the funds have been used to build and equip isolation centers across the country.

Mr. Emefiele said that 32 isolation centers have been built as of today, with a target to reach 39 isolation centers by the end of July.

The CBN governor added that CACOVID had also provided in-kind food palliatives to members of the public across the country to ameliorate the effects of the virus on their welfare.

He commended members of the coalition for their generous and selfless donations which have helped in achieving its common goal of helping the nation fight the spread of COVID-19. He also lauded the healthcare workers and the state government for their efforts in implementing strategies, caring for the infected patients and reducing the spread of the virus in the state.

Also, the Chief Executive, Dangote Industries Limited, Aliko Dangote said the Lagos Isolation Center was a model for what the coalition would build in other states.

Dangote, represented by Ms Zouera Youssoufou, Managing Director Aliko Dangote Foundation (ADF), said: “It is with great pride that we hand over the Yaba Isolation Center to Lagos State. More supports will come to the state from the coalition and we appreciate everyone’s contribution towards our goal.”

In his remarks, the Managing Director, Access Bank Plc, Mr. Herbert Wigwe said that Lagos was more vulnerable to spread of the virus due to its large population. He commended the state government for its efforts to reduce the spread and effect of the virus on the citizens. He also appreciated the state government’s support to CACOVID.

The Yaba Isolation center comes with a fully equipped medical laboratory and high dependency unit; personal protective equipment and other critical medical consumables; water and sewage treatment plants; 11kv power generator amongst other essentials. This is in addition to 34,000 test kits, sample collection swabs and infrared thermometers recently delivered to the NCDC.

Till date, CACOVID has committed billions of naira to build 38 fully equipped isolation centers across Nigeria with over 5,000 beds and critical medical equipment needed to fight the pandemic, exemplifying sustainable value addition from a partnership that truly works.

*Dangote Group
Read More
Merck appoints Ramsey Morad as Regional VP for MEAR
June 29, 2020 | 0 Comments

Ramsey Morad to lead the Healthcare business for Merck in Middle East, Africa, Turkey and Russia & CIS

DUBAI, United Arab Emirates, June 29, 2020,-/African Media Agency (AMA)/- Merck, a leading science and technology company, recently appointed Ramsey Morad as Regional Vice President for the Healthcare business in Middle East, Africa, Turkey and Russia & CIS (MEAR). Morad is now responsible for leading all business operations of Merck’s Healthcare business in this region.

Ramsey Morad, Regional Vice President for the Healthcare business in Middle East, Africa, Turkey and Russia & CIS (MEAR)

Morad is a well-regarded and experienced pharmaceutical executive with more than 25 years of industry experience across Europe, the Middle East and Africa.

“I am very excited to join Merck, a leader in science and technology, and head such a dedicated and driven organization. With its innovative, research-driven, specialty healthcare solutions, Merck is well-positioned to respond to the patients’ needs across the region and help them live a better life. I look forward to contributing to that by expanding our portfolio as well as extending its reach,” said Morad.

Merck’s Healthcare business in MEAR is represented in the therapeutic areas of General Medicine and Endocrinology (including Cardiometabolic Care), Fertility, Neurodegenerative Diseases and Oncology.

Joining from Allergan, Morad was the VP and Region Head of India, Middle East and Africa, leading the organization across 24 markets. Prior to Allergan, Morad was with Shire, in charge of the Eurasia, Middle East and Africa Region, where he led the integration efforts with Baxalta, established and expanded the company’s geographical footprint. Prior to Shire, Morad spent 17 years with MSD working in different roles of increasing responsibility across 6 countries including in regional leadership, general management and regional marketing.

Morad is a pharmacist with an MBA from Henley Business School. He was born and raised in the United States and over the years had the opportunity to live and work in several countries in Europe and the Middle East.

Distributed by African Media Agency (AMA) on behalf of Merck.

About Merck 
Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 57,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2019, Merck generated sales of € 16.2 billion in 66 countries. Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials.

Media Contact
Gaëlle Thisse
Email: gaelle@africanmediaagency.com

Source : African Media Agency (AMA)

Read More
Kenya:Another 2 patients die of Covid-19
June 26, 2020 | 0 Comments

By Samuel Ouma

Health Chief Administrative Secretary Dr. Mercy Mwangangi

The number of people who have succumbed to the coronavirus in Kenya has increased from 130 to 132 after Health Chief Administrative Secretary Dr. Mercy Mwangangi announced two more deaths.

Addressing the press on Thursday afternoon at Kenyatta National Hospital, Dr. Mwangangi confimed 178 new cases out of 3,918 samples tested the last 24 hours.

The new cases consisted of 175 Kenyans and 3 foreign nationals aged between 1 and 76 years. One hundred and twenty three (123) are males and 55 females.

Nairobi produced 100 cases, Kajiado (21), Migori (17), Kiambu (16), Busia (8), Mombasa (7), Machakos (4), Nakuru (2), Uasin Gishu (1), Kericho (1) and Taita.

On a positive note, the Ministry of Health has discharged 34 patients from various health facilities across the country hence recoveries stand at 1,857.

She hinted that a number of Nairobi estates are still the novel virus hotspots.

 “Kawangware, Kilimani and Westlands still remain hotspots and we will continue watching how the virus progresses in those regions. Mombasa too has been put on high alert. This means that you are at a high risk of contracting the virus if you are in Mombasa and Nairobi,” Mwangangi said.

Read More
Covid-19: Kenya’s cases cross over 5,000 mark
June 26, 2020 | 0 Comments

By Samuel Ouma

A member of Kenya Red Cross demonstrates hand-washing to members of the deaf community in Nairobi amid the COVID-19 pandemic [Georgina Smith/Al Jazeera]

The number of people who have contracted the coronavirus in Kenya has hit 5,206, said the Ministry of Health.

Speaking during the daily press briefing on the disease, Health Chief Administrative Secretary Dr. Mercy Mwangangi announced 254 new cases detected from 4,859 samples in the last 24 hours.

All the new patients are Kenyans aged between 4 and 92 years with 186 being males and 68 females.

The latest cases were reported in various counties as follows: Nairobi (127), Mombasa (36), Migori (29), Kajiado (22), Kiambu (12), Busia (9), Uasin Gishu (5), Murang’a (3), Machakos (2), Kilifi (2), Nakuru, (1), Siaya (1), Taita Taveta (1), Garissa, (1), Isiolo (1), Kakamega, (1), Kisii (1).

She disclosed that Nairobi, Mombasa and Busia lead with the number of patients with the novel virus. The Kenya’s capital has recorded 2,428, Mombasa 1,304and Busia 361 cases.

So far 40 out of 47 counties have announced positive cases.

Dr. Mwangangi further added that 151, 396 samples have been analyzed since the African nation reported its first case.

On recovery, she averred that 41 patients had been discharged from hospitals between Tuesday and Wednesday raising the number to 1,823. However, the number of fatalities has increased by 2 to 130.

Read More
Covid-19: Kenya’s cases cross over 5,000 mark
June 24, 2020 | 0 Comments

By Samuel Ouma

FILE PHOTO: Chief Administrative Secretary from the ministry of Health, DR. Mercy Mwangangi./Ministry of Health-Kenya.
FILE PHOTO: Chief Administrative Secretary from the ministry of Health, DR. Mercy Mwangangi./Ministry of Health-Kenya.

The number of people who have contracted the coronavirus in Kenya has hit 5,206, said the Ministry of Health.

Speaking during the daily press briefing on the disease, Health Chief Administrative Secretary Dr. Mercy Mwangangi announced 254 new cases detected from 4,859 samples in the last 24 hours.

All the new patients are Kenyans aged between 4 and 92 years with 186 being males and 68 females.

The latest cases were reported in various counties as follows: Nairobi (127), Mombasa (36), Migori (29), Kajiado (22), Kiambu (12), Busia (9), Uasin Gishu (5), Murang’a (3), Machakos (2), Kilifi (2), Nakuru, (1), Siaya (1), Taita Taveta (1), Garissa, (1), Isiolo (1), Kakamega, (1), Kisii (1).

She disclosed that Nairobi, Mombasa and Busia lead with the number of patients with the novel virus. The Kenya’s capital has recorded 2,428, Mombasa 1,304and Busia 361 cases.

So far 40 out of 47 counties have announced positive cases.

Dr. Mwangangi further added that 151, 396 samples have been analyzed since the African nation reported its first case.

On recovery, she averred that 41 patients had been discharged from hospitals between Tuesday and Wednesday raising the number to 1,823. However, the number of fatalities has increased by 2 to 130.

Read More
Pfizer and Wellcome Launch Surveillance Program to Combat Growing Threat of Antimicrobial Resistance in Sub-Saharan Africa
June 24, 2020 | 0 Comments

  • Antimicrobial resistance is a leading global health challenge that requires urgent action to ensure a safer world for everyone, everywhere
  • Effective surveillance and timely data feedback are critical for infection prevention and control programs, and informing appropriate use of anti-infectives 
  • New partnership in Ghana, Kenya, Malawi and Uganda will provide governments and public health community with critical decision-making information to help address AMR

NEW YORK, United States, 24 June 2020 -/African Media Agency (AMA)/- Pfizer Inc. (NYSE: PFE) and Wellcome today announced the launch of the Surveillance Partnership to Improve Data for Action on Antimicrobial Resistance (SPIDAAR), a new multi-year, public-private research collaboration with the governments of Ghana, Kenya, Malawi and Uganda to track resistance patterns and better understand the burden of antimicrobial resistance (AMR) on patients living in low- and middle-income countries. This first-of-its kind partnership will provide governments and health authorities with comprehensive data in four sub-Saharan African countries where there is a high burden of infectious diseases, insufficient data and lack of capacity to implement critically needed infection prevention and control programs.

As recently as 2017, nearly half (43%) of the countries on the African continent did not have available AMR data. Recent estimates project that mortality rates due to AMR in Africa could be nearly ten times that of North America and Europe by 2050 and that the economic impact could also be disproportionate, reducing gross domestic product (GDP) in low-income economies by as much as 5.6%. Timely data and effective surveillance are critical for identifying and tracking the emerging spread of resistant infections, building infection prevention and control programs and informing appropriate treatment to improve patient care. SPIDAAR will leverage the capabilities of Pfizer’s existing Antimicrobial Testing Leadership and Surveillance (ATLAS) platform to support implementation of the countries’ National Action Plans for AMR as specified by the World Health Organization (WHO).

“This partnership builds on Pfizer’s longstanding work in the area of antimicrobial surveillance and infectious diseases, to help create meaningful and sustainable solutions that strive to address today’s biggest health challenges and protect the world’s most vulnerable people,” said Pol Vandenbroucke, M.D., Chief Medical Officer of Pfizer’s hospital business. “Expanding on Pfizer’s existing ATLAS surveillance platform, the SPIDAAR program will offer transparent and open access to critically important data in the region, which we hope will enable countries in sub-Saharan Africa to better prepare for and respond to the serious and growing public health challenge of antimicrobial resistance.”

Planning for SPIDAAR began in July 2019 with government teams to identify health facilities across all four countries. The next phase of the partnership will initiate a surveillance program at the selected hospitals, where clinical isolates will be collected from infected hospitalized patients, identified, and tested for antimicrobial susceptibility. The confirmed culture will then be compared to treatment selected and prescribing guidelines.

Antibiotic resistance occurs when bacteria change in response to the use of antibiotics, making the antibiotics ineffective against the treatment of bacterial infections. A growing problem worldwide, it is becoming more difficult to treat common infections such as pneumonia, tuberculosis and salmonellosis . This can lead to longer hospital stays, higher medical costs and increased mortality.

“Drug-resistant infections are a huge global health threat, undermining advances in medicine and reversing health progress in countries like Ghana, Kenya, Malawi and Uganda over the last 20 years,” said Gemma Buckland Merrett, Ph.D., Science Lead, Drug-Resistant Infections, Wellcome. “Only through effective surveillance in hospitals and all healthcare settings can we gather the information essential to understand and track these dangerous infections, stop the spread, and protect patients. This is a complex global health problem which needs government, industry, and philanthropy working together, pooling resources and expertise, to allow health authorities and policymakers to make changes needed to prevent untreatable bacterial infections from claiming millions of lives.”

The SPIDAAR program includes a separate, prospective real-world data study that will be conducted in each of the four sub-Saharan countries to assess antimicrobial resistance rates as well as clinical and associated costs among patients with hospital-acquired infections. The partnership provides additional healthcare capacity building through advanced laboratory technique training for national and local laboratory teams.

Program data will be made available on Pfizer’s open-source ATLAS database as well as on Wellcome™s AMR Register. Created more than 15 years ago, ATLAS is the only industry-led, public-access platform that includes both antifungal and antibiotic resistance data. Today, this includes more than 685,000 bacterial and fungal isolates from 900-plus sites across more than 80 countries worldwide. The database includes nine of the 13 WHO priority pathogens that are considered the greatest threat to human life.

“Without a robust surveillance system, healthcare providers in sub-Saharan Africa are forced to use generalized guidelines to make prescribing decisions, which may not reflect trends in a given hospital or community,” said Charles Mwansambo, M.D., Chief of Health Services, Ministry of Health, Government of Malawi. “This program will provide us with real-world data on which drug resistance patterns are emerging and where, enabling front-line healthcare providers and health authorities to more successfully treat patients while preserving the effectiveness of medicines to manage infectious diseases.”

Distributed by African Media Agency (AMA) on behalf of PFIZER.

About Wellcome
Wellcome exists to improve health by helping great ideas to thrive. We support researchers, we take on big health challenges, we campaign for better science, and we help everyone get involved with science  and health research. We are a politically and financially independent foundation.To find out more about our work on drug-resistant infections, click here.

About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer NewsLinkedInYouTube and like us on Facebook at Facebook.com/Pfizer.

DISCLOSURE NOTICE: The information contained in this release is as of June [24], 2020. The Company assumes no obligation to update forward-looking statements contained in this release as a result of new information or future events or developments.

This release contains forward-looking information about the launch of the Surveillance Partnership to Improve Data for Action on Antimicrobial Resistance (SPIDAAR), a new multi-year, public-private research collaboration with the governments of Ghana, Kenya, Malawi and Uganda to track resistance patterns and better understand the burden of antimicrobial resistance (AMR) on patients living in low- and middle-income countries, including its potential benefits, that involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things, uncertainties related to the effectiveness of SPIDAAR, the uncertainties inherent in research and development; the uncertainties inherent in business and financial planning, including, without limitation, risks related to Pfizer’s business and prospects, adverse developments in Pfizer’s markets, or adverse developments in the U.S. or global capital markets, credit markets, regulatory environment or economies generally; the impact of COVID-19 on our business, operations and financial results; and competitive developments.

A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and in its subsequent reports on Form 10-Q, including in the sections thereof captioned “Risk Factors” and “Forward-Looking Information and Factors That May Affect Future Results,” as well as in its subsequent reports on Form 8-K, all of which are filed with the U.S. Securities and Exchange Commission and available at www.sec.govand www.pfizer.com.

Media Relations Contacts:

Pfizer: Sally Beatty
+1 (347) 330-7867
Sally.Beatty@Pfizer.com 

Wellcome: Maggie Stratton
M.Stratton@Wellcome.ac.uk

Source : African Media Agency (AMA)

Read More
African Development Bank approves EUR 88 million loan to Cameroon to finance COVID-19 response
June 24, 2020 | 0 Comments

The Board of Directors of the African Development Bank on Monday approved a EUR 88 million loan to Cameroon as direct budget support to finance the country’s COVID-19 crisis response.

The loan, to the country’s COVID-19 Crisis Response Budget Support Programme (PABRC), falls under the framework of the Bank’s COVID-19 Rapid Response Facility (CRF) of up to $10 billion, the institution’s main channel to cushion African countries from the economic and health impacts of the crisis.

In Cameroon, the pandemic has revealed the structural weaknesses of the country’s health system and economy, particularly the limited human and financial resources allocated to the health sector.

The PABRC’s goal is to check the spread of the coronavirus, to save lives and to mitigate its adverse socio-economic effects on the Central African country, particularly on households and businesses. The programme also involves longer-term actions to build the resilience of the economy as a basis for recovery.

It will support the implementation of a health response plan to improve testing and ensure early detection and rapid management of the virus, thus reducing case fatality and improving the recovery rate. It will also support the most vulnerable in society by paying family allowances to staff of companies unable to pay social security contributions as well as distributing health kits.  

“Women play a key role in the fight against the spread of COVID-19 as wives, mothers, caregivers and community resource persons. The social protection and economic resilience actions under this support will particularly target women and the households and businesses headed by them,” Bank Acting Director General and Country Manager for Cameroon, Solomane Kone said.

Measures to sustain economic activity and safeguard employment will include value-added tax (VAT) credits to restore the cash position of enterprises as well as procuring inputs to support strategic agricultural value chains including poultry, fish, seeds and cereals. It will also support key small and medium-sized enterprises in the agribusiness, health and education sectors.

This operation complements the Bank’s $13 million special emergency project for Economic and Monetary Community of Central Africa(CEMAC) member countries and the Democratic Republic of Congo, to fight the COVID-19 pandemic, which was approved earlier this month.

COVID-19 has broken out at a time when the Cameroonian economy, the largest and most diversified in the Central Africa, is recovering from the 2014 shock caused by a sharp fall in the world prices of the country’s main export products ­– oil, cocoa and timber. Without support, the spread of COVID-19 in Cameroon could compromise the reform drive and jeopardise the progress made in recent years.

The first confirmed case of COVID-19 in Cameroon was identified on 6 March 2020. By 22 June, the Central African country had more than 12,041 confirmed cases, including 308  deaths and 7,740  recoveries. The Centre (Yaoundé) and Littoral (Douala) Regions have the highest number of cases, representing about 55.8% and 32.2% of the total, respectively.

*AFDB

Read More
Safe Hands Kenya scales up mass sanitation drive against COVID-19 to reach 2 million Kenyans
June 24, 2020 | 0 Comments

Alliance of Kenyan companies and community organisations expands free soap, hand-washing stations, face masks, public spraying programmes and behaviour change campaign nationwide

Safe Hands Kenya , a mission-driven alliance of Kenyan companies and community organisations is scaling up its mass sanitation drive to combat COVID-19. 1.25 million people have been reached over the past two months in Nairobi and the alliance is on track to reach 2 million people by the end of June. 87 tonnes of locally produced soap and 1500 locally manufactured handwashing stations have already been distributed, while 500,000 locally manufactured masks are being distributed. 

Safe Hands is prioritising activities for those most in need – those in informal settlements, where social distancing and other recommended approaches to curbing the spread of COVID-19 are nearly impossible asks. The diversity of the alliance is the key to its ability to mobilise at speed, pilot multiple intervention programmes, iterate swiftly and achieve scale. Safe Hands Kenya is composed of over 30 private sector and community actors with strong established networks, credibility and trust within the target communities. Founding coalition members Dalberg and KOKO Networks have been instrumental in catalysing and driving Safe Hands Kenya activities, donating substantial time and resources to launching the effort.

Andrew Waititu, CEO of Safe Hands Kenya noted, “The actions up and down the Safe Hands Kenya supply chain are spurring economic activity and acting as a vital stimulus for Kenyan families working within local manufacturing and supply chains. The Dandora public spaces disinfectant campaign has created 300 temporary jobs, the Mega Apparel factory is engaging 140 people to make masks and we have engaged local artisans and tradespeople to assist in the manufacture of handwashing stations. It is critical to keep as many people in work as possible and to enable skills development and training.” 

The alliance has built a geospatial demand and supply allocation map, using several layers of data to target with precision, and partners distribute products using IOT-enabled technologies. The immediate provision of the tools for rapid mass sanitationaccompanied by a highly creative behaviour change campaign to motivate people to use them effectively, is the most effective way to keep people safe and society functioning. 

The alliance’s approach to product design and distribution is also informed by human-centred design principles to maximise the rate of adoption. The behaviour change campaign – Tiba Ni Sisi (Swahili for “We are the Cure”) – is designed to capture people’s imaginations and pay public health dividends long beyond the COVID-19 pandemic by  improving general hygiene practices, with concomitant benefits for other sanitation-related diseases and deaths.  

Charles Gachanga Gichonge, CEO of Dandora Transformation League, added “Dandora has been amongst the most vulnerable areas in Nairobi city. For the last 2 months SHK and DTL have managed to keep Covid-19 at bay. So far, so good!“

Dandora community member and chairlady of Pink Court Monicah Ningari commented “We are glad that Safe Hands Kenya have brought us these hand washing stations. They have helped society, in particular children and mothers.  We are praying they bring us even more stations because they are helping us in fighting coronavirus.”

Additional Safe Hands chapters are now up and running in Tanzania and Ethiopia. Safe Hands Kenya is creating an open-source operations manual to enable organisations exploring how to set up similar alliances to accelerate their speed to market as a demonstration of its commitment to being a learning, sharing organisation.

Safe Hands Kenya is an alliance of private companies and community organisations that has joined together to provide essential products and services, like hand washing and public sanitation services, for free to all Kenyans as a first line of defence against COVID-19.

The alliance includes technology-based distribution companies, input suppliers, manufacturers, media houses and community organisations and has assembled a full-time project team that includes experts across supply chains, user experience and behavioural change. All members have pledged to uphold three key principles: 1) zero margin: this is for impact, not profit; 2) speed is critical: every day counts; and 3) last-mile saturation: we leave no-one behind.

*Safe Hands Kenya

Read More
Private Sector Health Alliance of Nigeria (PSHAN), Aig-Imoukhuede kick off Design Phase of Primary Healthcare Centre (PHC) Adoption Programme
June 22, 2020 | 0 Comments
Mr. Aigboje Aig-Imoukhuede
Under this private sector driven initiative, universal health access will be provided for low-income citizens residing in rural and urban areas through the Adopt-a-Health Facility Programme.

Aigboje Aig-Imoukhuede, in collaboration with the Private Sector Health Alliance of Nigeria (PSHAN) have unveiled a new initiative geared towards significantly improving Nigeria’s healthcare system at the grassroots level.

The innovative strategy, in furtherance of a vision from an earlier stakeholders’ roundtable, entails delivering one Primary Healthcare Centre (PHC) in each of Nigeria’s 774 Local Government Areas (LGAs) at global standards.

Under this private sector driven initiative, universal health access will be provided for low-income citizens residing in rural and urban areas through the Adopt-a-Health Facility Programme (ADHFP).

ADHFP, according to a release issued by the CEO of PSHAN, Mr. Sonny Nwarisi, will be sponsored by a group of Angel Investors and other institutions. These “Angels” will each take responsibility for one or more PHCs – they will build and operate the PHCs for the period of adoption under strict rules and guidelines. The ADHFP is a multi-impact initiative with several benefits including: Saving lives, Improvement in health outcomes, Job creation, and Gender empowerment

Mr. Aig-Imoukhuede and PSHAN recently initiated the ADHFP design phase which will be handled by Vesta Healthcare Partners, a global healthcare consultancy firm.

This consultancy engagement is expected to deliver key program components such as: Legal and Regulatory Framework, PPP Framework, PHC facility and management standards, Financing Arrangements, Governance Arrangements, Supply Chain Management, and Technology & Systems.

The design phase will involve active participation of notable development-focused organizations including: Global Citizen, ABCHealth, Bill & Melinda Gates Foundation, United Nations Economic Commission for Africa, World Bank, International Finance Corporation (IFC), MTN Nigeria Plc, Dangote Group, Zenith Bank, Access Bank, Stanbic-IBTC Bank, PwC, Cisco, Ford Foundation, Nigerian Stock Exchange, and Flying Doctors Nigeria.

Others include Africa Practice, Cedar Advisory Partners, GBCHealth, Health Federation of Nigeria, Health Law, Eti-Osa Local Government, JNC International Ltd, Johnson & Johnson, Justice in Healthcare, Lagos State Government, MSD for Mothers, Nigeria Economic Summit Group (NESG), ONE Campaign, PharmAccess Foundation, Women-At-Risk International Foundation as well as the Lagos State Government and the SSA to the President on Sustainable Development Goals among others.

*Source Dangote Group
Read More
Covid-19: Janngo joins forces with The African Union Chairperson, Special Envoy Strive Masiyiwa & the Africa CDC, to launch the Africa Medical Supplies Platform, Africa’s Unified Continental Response to fight the pandemic
June 19, 2020 | 0 Comments
The platform serves as a unique interface enabling volume aggregation, quota management, payment facilitation as well as logistics & transportation.


The Africa Medical Supplies Platform (AMSP) adopted as a single online marketplace to enable the supply of COVID-19-related critical medical equipment in Africa was developed under the leadership of African Union Special Envoy, Strive Masiyiwa and powered by Janngo (www.Janngo.africa) on behalf of the African Union’s Africa Centres for Disease Control and Prevention (Africa CDC) and in partnership with African Export-Import Bank (Afreximbank), the United Nations Economic Commission for Africa (ECA) and other leading African & International Corporations, Institutions & Foundations.

The Africa Medical Supplies Platform (AMSP) unlocks immediate access to an African & global base of vetted manufacturers and procurement strategic partners and enables African Union Member States to purchase certified medical equipment such as diagnostic kits, PPE and clinical management devices with improved cost effectiveness & transparency. The platform serves as a unique interface enabling volume aggregation, quota management, payment facilitation as well as logistics & transportation to ensure equitable & efficient access to critical supplies for African governments. The Afreximbank will facilitate payments while logistics partners including African national carriers, global freight forwarders will expedite delivery.

“The Africa Medical Supply Platform is just one innovation that African countries have developed ourselves, to help mitigate the devastating impact of this pandemic that threatens both the health of our people and our national economies. We are already getting requests from other parts of the world to franchise the AMSP concept,” said Special Envoy Strive Masiyiwa. He adds “Africa is leading the way with this online solution to ensure all of our governments get access to PPEs and other urgent medical supplies they need, at fair prices.”

“We commit to providing market intelligence on where the manufacturers are, facilitating pooled procurement when financial resources are made available through this initiative, and distributing these products to respective African destinations,” said Dr John Nkengasong, Director of Africa CDC.

“As a mission-driven organization, we are committed to serving our beloved continent in these trying times, leveraging Janngo’s 3 main pillars :
our venture building capabilities, technology expertise & cross-border marketplace track-record to enable this platform initiative under the leadership of Special Envoy Strive Masiyiwa;
our financial & human capital to support our portfolio & dealflow more than ever, in particular logistics, healthtech & fintech startups on the frontline of the covid response;
our knowledge sharing sessions & webinars via Janngo Academy to empower our broader community of entrepreneurs to build resilience & adjust their activities to the pandemic effect.

The next 100 days are critical to turnaround the exponential trend of cases and deaths : both our sense of purpose & sense of urgency have never been stronger” commented Fatoumata Bâ, Founder & Executive Chair of Janngo and Managing Partner of Janngo Capital.

About Janngo:
Janngo  builds, grows and invests in pan-African digital champions with proven business models and inclusive social impact. We build digital ecosystems in high growth sectors by providing business support and digital platforms allowing Small and Medium Enterprises (SMEs) to scale and contribute to the economic empowerment of youth and women through job creation and capacity building.

About the Africa Medical Supplies Platform:
The Africa Medical Supplies Platform (AMSP) (www.AMSP.Africa) is a non-profit initiative launched by the African Union as an immediate, integrated and practical response to the Covid-19 pandemic. The online platform was developed under the leadership of African Union Special Envoy, Strive Masiyiwa and powered by Janngo on behalf of the African Union’s Africa Centres for Disease Control and Prevention (Africa CDC) and in partnership with African Export-Import Bank (Afreximbank) and United Nations Economic Commission for Africa (ECA) with the support of leading African & international Institutions, Foundations & Corporations as well as Governments of China, Canada & France.
About the African Union Africa CDC:
Africa CDC (www.AfricaCDC.org) is a specialized technical institution of the African Union supporting Member States to strengthen their capacity to prepare for and respond to disease threats and other public health emergencies. 
*SOURCE Janngo
Read More
Kenyan men badly hit by Covid-19
June 16, 2020 | 0 Comments

By Samuel Ouma

A Kenyan health worker uses a nasal swab to test a man for COVID-19 in the Kawangware slums of the capital, Nairobi.(Luis Tato / AFP/Getty Images)
A Kenyan health worker uses a nasal swab to test a man for COVID-19 in the Kawangware slums of the capital, Nairobi.(Luis Tato / AFP/Getty Images)

The number of men infected with the Coronavirus in Kenya is higher than that of women, said the Health Minister Mutahi Kagwe.

Kagwe attributed the soaring cases to the shifting behaviours between the two genders with men alleged to be lacking vigilance.

“We need to understand why so many men are getting this virus. If we were able to drop the number of men to the level of number of women you can see we’d drop the numbers substantially. I think it is to do with behaviour. Women essentially are exhibiting a more careful and consistent approach to this disease than men. We as men must adopt the same attitude,” noted the Minister.

Speaking during the daily press brief on Covid-19, Kagwe announced that in the last 24 hours 133 new people contracted the new virus out of 3,255 samples analyzed.

Of the 133, eighty eight (88) were males and 45 females aged between 13 and 90 years-old.

The new infections were reported in the following areas: Nairobi (86), Mombasa (27), Kiambu (7), Busia (5), Kilifi (2), Kajiado (2), Migori (2), Machakos (1).

The number of recoveries rose to 1,326 after 40 more patients were discharged across the country.

On sad note, one patient succumbed to the respiratory disease bringing the death toll to 105.

Up-to-date Kenya has tested 121, 956 samples.

The African nation confirmed the first case of Covid-19 on March 13, 2020.

Read More
Covid-19: Kenya’s tally hit 3,727
June 15, 2020 | 0 Comments

By Samuel Ouma

A member of Kenya Red Cross demonstrates hand-washing to members of the deaf community in Nairobi amid the COVID-19 pandemic [Georgina Smith/Al Jazeera]

The Ministry of Health on Monday, June 15, announced 133 new cases of Covid-19 bringing the total number of confirmed cases to 3,727.

Addressing the journalists during daily covid-19 press briefings, Health Cabinet Secretary (CS) Mutahi Kagwe said the new cases were confirmed from 3,365 samples tested between Sunday and Monday.

The youngest patient is 1-year-old while the oldest is 70-years-old with 93 being males and 40 females.

The cases were reported in various parts of the country as follows: Mombasa (61), Nairobi (53), Kilifi (7), Busia (6), Kiambu (2), Kajiado, Nakuru, Murang’a, and Kitui 1 case each.

At the same Kagwe noted that 33 patients had been charged from quarantine facilities and hospitals across the country raising the number of recoveries to 1,286.

Unfortunately, the country lost one patient increasing the figures of Covid-19 deaths to 104.

The CS was speaking in Nyandarua County, Central Kenya.

So far 38 out of 47 counties have confirmed positive cases.

“I want to appeal to the people of Nyandarua to maintain this status. What happens elsewhere is that when you get one case, and then another, it grows exponentially and soon you start to hear the kind of numbers you’re hearing in Nairobi and elsewhere,” he said.

By Monday Kenya had tested 118, 701 samples.

Read More
1 2 3 54